Evidence map›Paper›PMID 37428188›Full record

ReviewApplied microbiology and biotechnology2023

Research progress and application of enzymatic synthesis of glycosyl compounds.

Yujuan Shen, Yuanyuan Xia, Xianzhong Chen

Abstract readReview
PubMed Publisher
In one paragraph

Review in Applied microbiology and biotechnology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
3.5field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 13 citations in OpenAlex.

  1. Natural novel vitamin C derivative, 2-Chinese herbal medicines · 2026
    Review
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Yujuan ShenKey Laboratory of Industrial Biotechnology, Ministry of Education, Jiangnan University, Wuxi, China.
Yuanyuan XiaKey Laboratory of Industrial Biotechnology, Ministry of Education, Jiangnan University, Wuxi, China. yyxia@jiangnan.edu.cn.
Xianzhong ChenKey Laboratory of Industrial Biotechnology, Ministry of Education, Jiangnan University, Wuxi, China. xzchen@jiangnan.edu.cn.ORCID http://orcid.org/0000-0003-0695-3382
Jiangnan University · CN

Funding

Key Research and Development Program of China No. 2021YFC2100102-03National Natural Science Foundation of China No. 32001064National Natural Science Foundation of China No. 32271533
6 · The paper itself

Abstract

Glucoside compounds are widely found in nature and have garnered significant attention in the medical, cosmetics, and food industries due to their diverse pharmaceutical properties, biological activities, and stable application characteristics. Glycosides are mainly obtained by direct extraction from plants, chemical synthesis, and enzymatic synthesis. Given the challenges associated with plant extraction, such as low conversion rates and the potential for environmental pollution with chemical synthesis, our review focuses on enzymatic synthesis. Here, we reviewed the enzymatic synthesis methods of 2-O-α-D-glucopyranosyl-L-ascorbic acid (AA-2G), 2-O-α-D-glucosyl glycerol (α-GG), arbutin and α-glucosyl hesperidin (Hsp-G), and other glucoside compounds. The types of enzymes selected in the synthesis process are comprehensively analyzed and summarized, as well as a series of enzyme transformation strategies adopted to improve the synthetic yield. KEY POINTS: • Glycosyl compounds have applications in the biomedical and food industries. • Enzymatic synthesis converts substrates into products using enzymes as catalysts. • Substrate bias and specificity are key to improving substrate conversion.

Indexed as

Ascorbic AcidGlucosidesArbutinArbutinAscorbic Acidascorbic acid 2-O-glucosideGlucosides2-O-α-D-glucopyranosyl-L-ascorbic acid2-O-α-D-glucosyl glycerolArbutinEnzymatic synthesisGlucoside compoundsα-Glucosyl hesperidin

Identifiers

PMID37428188
OpenAlexW4383710169

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.